-
1
-
-
0027981293
-
Cytokines in major depression
-
Maes M. Cytokines in major depression. Biol Psychiatry (1994) 36(7):498-9. doi: 10.1016/0006-3223(94)90652-1
-
(1994)
Biol Psychiatry
, vol.36
, Issue.7
, pp. 498-499
-
-
Maes, M.1
-
2
-
-
0026473129
-
Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio
-
Maes M, Stevens W, DeClerck L, Bridts C, Peeters D, Schotte C, et al. Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio. Acta Psychiatr Scand (1992) 86(6):423-31. doi:10.1111/j.1600-0447.1992.tb03292.x
-
(1992)
Acta Psychiatr Scand
, vol.86
, Issue.6
, pp. 423-431
-
-
Maes, M.1
Stevens, W.2
DeClerck, L.3
Bridts, C.4
Peeters, D.5
Schotte, C.6
-
3
-
-
0027295619
-
Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis
-
Muller N, Hofschuster E, Ackenheil M, Mempel W, Eckstein R. Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry (1993) 17(5):713-30. doi:10.1016/0278-5846(93)90055-W
-
(1993)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.17
, Issue.5
, pp. 713-730
-
-
Muller, N.1
Hofschuster, E.2
Ackenheil, M.3
Mempel, W.4
Eckstein, R.5
-
4
-
-
24644433745
-
Th1, Th2, and Th3 cytokine alterations in major depression
-
Myint AM, Leonard BE, Steinbusch HW, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord (2005) 88(2):167-73. doi:10.1016/j.jad.2005.07.008
-
(2005)
J Affect Disord
, vol.88
, Issue.2
, pp. 167-173
-
-
Myint, A.M.1
Leonard, B.E.2
Steinbusch, H.W.3
Kim, Y.K.4
-
5
-
-
0035089606
-
Inflammatory markers in major depression and melancholia
-
Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, et al. Inflammatory markers in major depression and melancholia. J Affect Disord (2001) 63(1-3):93-102. doi:10.1016/S0165-0327(00)00157-9
-
(2001)
J Affect Disord
, vol.63
, Issue.1-3
, pp. 93-102
-
-
Rothermundt, M.1
Arolt, V.2
Peters, M.3
Gutbrodt, H.4
Fenker, J.5
Kersting, A.6
-
6
-
-
84893345725
-
Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder
-
Carvalho LA, Bergink V, Sumaski L, Wijkhuijs J, Hoogendijk WJ, Birkenhager TK, et al. Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Transl Psychiatry (2014) 4:e344. doi:10.1038/tp.2013.118
-
(2014)
Transl Psychiatry
, vol.4
-
-
Carvalho, L.A.1
Bergink, V.2
Sumaski, L.3
Wijkhuijs, J.4
Hoogendijk, W.J.5
Birkenhager, T.K.6
-
7
-
-
75849155537
-
A meta-analysis of cytokines in major depression
-
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry (2010) 67(5):446-57. doi:10.1016/j.biopsych.2009.09.033
-
(2010)
Biol Psychiatry
, vol.67
, Issue.5
, pp. 446-457
-
-
Dowlati, Y.1
Herrmann, N.2
Swardfager, W.3
Liu, H.4
Sham, L.5
Reim, E.K.6
-
8
-
-
84940609837
-
Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder
-
Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimaki M. Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav Immun (2015) 49:206-15. doi:10.1016/j.bbi.2015.06.001
-
(2015)
Brain Behav Immun
, vol.49
, pp. 206-215
-
-
Haapakoski, R.1
Mathieu, J.2
Ebmeier, K.P.3
Alenius, H.4
Kivimaki, M.5
-
9
-
-
65649152524
-
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis
-
Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med (2009) 71(2):171-86. doi:10.1097/PSY.0b013e3181907c1b
-
(2009)
Psychosom Med
, vol.71
, Issue.2
, pp. 171-186
-
-
Howren, M.B.1
Lamkin, D.M.2
Suls, J.3
-
10
-
-
0031971507
-
The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression
-
Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, et al. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord (1998) 49(3):211-9. doi:10.1016/S0165-0327(98)00025-1
-
(1998)
J Affect Disord
, vol.49
, Issue.3
, pp. 211-219
-
-
Song, C.1
Lin, A.2
Bonaccorso, S.3
Heide, C.4
Verkerk, R.5
Kenis, G.6
-
11
-
-
0022635845
-
Depression, immunocompetence, and prostaglandins of the E series
-
Calabrese JR, Skwerer RG, Barna B, Gulledge AD, Valenzuela R, Butkus A, et al. Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res (1986) 17(1):41-7. doi:10.1016/0165-1781(86)90040-5
-
(1986)
Psychiatry Res
, vol.17
, Issue.1
, pp. 41-47
-
-
Calabrese, J.R.1
Skwerer, R.G.2
Barna, B.3
Gulledge, A.D.4
Valenzuela, R.5
Butkus, A.6
-
12
-
-
0020526435
-
CSF prostaglandin levels in depressed and schizophrenic patients
-
Linnoila M, Whorton AR, Rubinow DR, Cowdry RW, Ninan PT, Waters RN. CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry (1983) 40(4):405-6. doi:10.1001/archpsyc.1983.01790040059008
-
(1983)
Arch Gen Psychiatry
, vol.40
, Issue.4
, pp. 405-406
-
-
Linnoila, M.1
Whorton, A.R.2
Rubinow, D.R.3
Cowdry, R.W.4
Ninan, P.T.5
Waters, R.N.6
-
13
-
-
0024520842
-
Salivary prostaglandin concentrations: possible state indicators for major depression
-
Nishino S, Ueno R, Ohishi K, Sakai T, Hayaishi O. Salivary prostaglandin concentrations: possible state indicators for major depression. Am J Psychiatry (1989) 146(3):365-8. doi:10.1176/ajp.146.3.365
-
(1989)
Am J Psychiatry
, vol.146
, Issue.3
, pp. 365-368
-
-
Nishino, S.1
Ueno, R.2
Ohishi, K.3
Sakai, T.4
Hayaishi, O.5
-
14
-
-
0023867453
-
Increased level of salivary prostaglandins in patients with major depression
-
Ohishi K, Ueno R, Nishino S, Sakai T, Hayaishi O. Increased level of salivary prostaglandins in patients with major depression. Biol Psychiatry (1988) 23(4):326-34. doi:10.1016/0006-3223(88)90283-1
-
(1988)
Biol Psychiatry
, vol.23
, Issue.4
, pp. 326-334
-
-
Ohishi, K.1
Ueno, R.2
Nishino, S.3
Sakai, T.4
Hayaishi, O.5
-
15
-
-
67650083320
-
Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial
-
Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety (2009) 26(7):607-11. doi:10.1002/da.20589
-
(2009)
Depress Anxiety
, vol.26
, Issue.7
, pp. 607-611
-
-
Akhondzadeh, S.1
Jafari, S.2
Raisi, F.3
Nasehi, A.A.4
Ghoreishi, A.5
Salehi, B.6
-
16
-
-
33745617042
-
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
-
Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry (2006) 11(7):680-4. doi:10.1038/sj.mp.4001805
-
(2006)
Mol Psychiatry
, vol.11
, Issue.7
, pp. 680-684
-
-
Muller, N.1
Schwarz, M.J.2
Dehning, S.3
Douhe, A.4
Cerovecki, A.5
Goldstein-Muller, B.6
-
17
-
-
84885788151
-
Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis
-
Na KS, Lee KJ, Lee JS, Cho YS, Jung HY. Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry (2014) 48:79-85. doi:10.1016/j.pnpbp.2013.09.006
-
(2014)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.48
, pp. 79-85
-
-
Na, K.S.1
Lee, K.J.2
Lee, J.S.3
Cho, Y.S.4
Jung, H.Y.5
-
18
-
-
0033975012
-
Cytokine production and treatment response in major depressive disorder
-
Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology (2000) 22(4):370-9. doi:10.1016/s0893-133x(99)00134-7
-
(2000)
Neuropsychopharmacology
, vol.22
, Issue.4
, pp. 370-379
-
-
Lanquillon, S.1
Krieg, J.C.2
Bening-Abu-Shach, U.3
Vedder, H.4
-
19
-
-
33845213789
-
Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy
-
O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res (2007) 41(3-4):326-31. doi:10.1016/j.jpsychires.2006.05.013
-
(2007)
J Psychiatr Res
, vol.41
, Issue.3-4
, pp. 326-331
-
-
O'Brien, S.M.1
Scully, P.2
Fitzgerald, P.3
Scott, L.V.4
Dinan, T.G.5
-
20
-
-
84929104982
-
Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy
-
Grosse L, Carvalho LA, Birkenhager TK, Hoogendijk WJ, Kushner SA, Drexhage HA, et al. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Psychopharmacology (Berl) (2016) 233(9):1679-88. doi:10.1007/s00213-015-3943-9
-
(2016)
Psychopharmacology (Berl)
, vol.233
, Issue.9
, pp. 1679-1688
-
-
Grosse, L.1
Carvalho, L.A.2
Birkenhager, T.K.3
Hoogendijk, W.J.4
Kushner, S.A.5
Drexhage, H.A.6
-
21
-
-
84943357496
-
Inflammation and clinical response to treatment in depression: a meta-analysis
-
Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, Cleare AJ. Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol (2015) 25(10):1532-43. doi:10.1016/j.euroneuro.2015.06.007
-
(2015)
Eur Neuropsychopharmacol
, vol.25
, Issue.10
, pp. 1532-1543
-
-
Strawbridge, R.1
Arnone, D.2
Danese, A.3
Papadopoulos, A.4
Herane Vives, A.5
Cleare, A.J.6
-
22
-
-
34547794475
-
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
-
Muller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry (2007) 12(11):988-1000. doi:10.1038/sj.mp.4002006
-
(2007)
Mol Psychiatry
, vol.12
, Issue.11
, pp. 988-1000
-
-
Muller, N.1
Schwarz, M.J.2
-
23
-
-
0242720163
-
Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression
-
Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses (2003) 61(5-6):519-25. doi:10.1016/S0306-9877(03)00207-X
-
(2003)
Med Hypotheses
, vol.61
, Issue.5-6
, pp. 519-525
-
-
Myint, A.M.1
Kim, Y.K.2
-
24
-
-
33846018443
-
Kynurenine pathway in major depression: evidence of impaired neuroprotection
-
Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H, Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord (2007) 98(1-2):143-51. doi:10.1016/j.jad.2006.07.013
-
(2007)
J Affect Disord
, vol.98
, Issue.1-2
, pp. 143-151
-
-
Myint, A.M.1
Kim, Y.K.2
Verkerk, R.3
Scharpe, S.4
Steinbusch, H.5
Leonard, B.6
-
25
-
-
0021716040
-
The alteration of membrane proteins in human erythrocyte membranes induced by quinolinic acid, an endogenous neurotoxin. Correlation of effect with structure
-
Farmer BT II, Nicholas MM, Butterfield DA. The alteration of membrane proteins in human erythrocyte membranes induced by quinolinic acid, an endogenous neurotoxin. Correlation of effect with structure. Biochim Biophys Acta (1984) 778(2):260-8. doi:10.1016/0005-2736(84)90367-5
-
(1984)
Biochim Biophys Acta
, vol.778
, Issue.2
, pp. 260-268
-
-
Farmer, B.T.1
Nicholas, M.M.2
Butterfield, D.A.3
-
26
-
-
0019967973
-
An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid
-
Perkins MN, Stone TW. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res (1982) 247(1):184-7. doi:10.1016/0006-8993(82)91048-4
-
(1982)
Brain Res
, vol.247
, Issue.1
, pp. 184-187
-
-
Perkins, M.N.1
Stone, T.W.2
-
27
-
-
77953194779
-
Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
-
Oades RD, Myint AM, Dauvermann MR, Schimmelmann BG, Schwarz MJ. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention. Behav Brain Funct (2010) 6:32. doi:10.1186/1744-9081-6-32
-
(2010)
Behav Brain Funct
, vol.6
, pp. 32
-
-
Oades, R.D.1
Myint, A.M.2
Dauvermann, M.R.3
Schimmelmann, B.G.4
Schwarz, M.J.5
-
28
-
-
0033006124
-
Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis
-
Morrison PF, Morishige GM, Beagles KE, Heyes MP. Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis. J Neurochem (1999) 72(5):2135-44. doi:10.1046/j.1471-4159.1999.0722135.x
-
(1999)
J Neurochem
, vol.72
, Issue.5
, pp. 2135-2144
-
-
Morrison, P.F.1
Morishige, G.M.2
Beagles, K.E.3
Heyes, M.P.4
-
29
-
-
0020702374
-
Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain
-
Schwarcz R, Whetsell WO Jr, Mangano RM. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science (1983) 219(4582):316-8. doi:10.1126/science.6849138
-
(1983)
Science
, vol.219
, Issue.4582
, pp. 316-318
-
-
Schwarcz, R.1
Whetsell, W.O.2
Mangano, R.M.3
-
30
-
-
81155157520
-
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?
-
Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation (2011) 8:94. doi:10.1186/1742-2094-8-94
-
(2011)
J Neuroinflammation
, vol.8
, pp. 94
-
-
Steiner, J.1
Walter, M.2
Gos, T.3
Guillemin, G.J.4
Bernstein, H.G.5
Sarnyai, Z.6
-
31
-
-
84867582069
-
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study
-
Abbasi SH, Hosseini F, Modabbernia A, AshrafiM, Akhondzadeh S. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord (2012) 141(2-3):308-14. doi:10.1016/j.jad.2012.03.033
-
(2012)
J Affect Disord
, vol.141
, Issue.2-3
, pp. 308-314
-
-
Abbasi, S.H.1
Hosseini, F.2
Modabbernia, A.3
Ashrafi, M.4
Akhondzadeh, S.5
-
32
-
-
21244495606
-
IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity
-
Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpe S, Maes M. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry (2005) 10(6):538-44. doi:10.1038/sj.mp.4001600
-
(2005)
Mol Psychiatry
, vol.10
, Issue.6
, pp. 538-544
-
-
Wichers, M.C.1
Koek, G.H.2
Robaeys, G.3
Verkerk, R.4
Scharpe, S.5
Maes, M.6
|